Market Restraints: The Challenges of Rarity and High Treatment Costs Despite its critical importance, the Global Botulism Illness Market faces significant restraints that temper its growth potential. The foremost challenge is the extreme rarity of the disease. With only a few hundred cases of natural botulism reported globally each year, the commercial market size for treatments is inherently limited. This rarity makes it difficult for pharmaceutical companies...